tgaac94
Gene therapyexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2004 (NCT00617032)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- TNF-alphaSupplementation
TNF supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- tgaac94
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00126724 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2005 | AmpliPhi Biosciences Corporation |
| NCT00617032 | Phase 1 | Feb 1, 2004 | AmpliPhi Biosciences Corporation |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| AmpliPhi Biosciences Corporation | For profit | 2 | 2 | 2 | 2004 |
1 organizations
Page 1 / 1